Every January, the JPM Healthcare Conference sets the tone for the year ahead in pharma and biotech. It’s where strategy meets scrutiny—where investors, analysts, media, and stakeholders look for credible signals about pipelines, leadership, innovation, and long-term growth. This year, I experienced JPM in person for the first time—and it reinforced just how much influence […]
